These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31244850)

  • 61. DCs and NK cells: critical effectors in the immune response to HIV-1.
    Altfeld M; Fadda L; Frleta D; Bhardwaj N
    Nat Rev Immunol; 2011 Mar; 11(3):176-86. PubMed ID: 21350578
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS.
    Huang CB; Alimova YV; Ebersole JL
    Cell Immunol; 2011; 268(2):105-11. PubMed ID: 21420664
    [TBL] [Abstract][Full Text] [Related]  

  • 63. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice.
    Li G; Cheng M; Nunoya J; Cheng L; Guo H; Yu H; Liu YJ; Su L; Zhang L
    PLoS Pathog; 2014 Jul; 10(7):e1004291. PubMed ID: 25077616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HIV interactions with dendritic cells: has our focus been too narrow?
    Donaghy H; Wilkinson J; Cunningham AL
    J Leukoc Biol; 2006 Nov; 80(5):1001-12. PubMed ID: 16923917
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection.
    Espinar-Buitrago M; Muñoz-Fernández MA
    Front Immunol; 2021; 12():719664. PubMed ID: 35058917
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes.
    Engering A; Van Vliet SJ; Geijtenbeek TB; Van Kooyk Y
    Blood; 2002 Sep; 100(5):1780-6. PubMed ID: 12176900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.
    Ayinde D; Bruel T; Cardinaud S; Porrot F; Prado JG; Moris A; Schwartz O
    J Virol; 2015 Jul; 89(14):6994-7006. PubMed ID: 25926647
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.
    Frleta D; Ochoa CE; Kramer HB; Khan SA; Stacey AR; Borrow P; Kessler BM; Haynes BF; Bhardwaj N
    J Clin Invest; 2012 Dec; 122(12):4685-97. PubMed ID: 23160198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Technical advance. Measurement of iNKT cell responses at the single-cell level against rare HIV-1-infected dendritic cells in a mixed culture.
    Andersson SK; Paquin-Proulx D; Kroll M; Sandberg JK; Moll M
    J Leukoc Biol; 2013 Mar; 93(3):449-55. PubMed ID: 23264676
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
    Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
    PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interactions between HIV-1 and innate immunity in dendritic cells.
    Silvin A; Manel N
    Adv Exp Med Biol; 2013; 762():183-200. PubMed ID: 22975876
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dendritic cell vaccination and viral infection--animal models.
    Ludewig B
    Curr Top Microbiol Immunol; 2003; 276():199-214. PubMed ID: 12797449
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antiviral immune responses by human langerhans cells and dendritic cells in HIV-1 infection.
    van den Berg LM; Geijtenbeek TB
    Adv Exp Med Biol; 2013; 762():45-70. PubMed ID: 22975871
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.
    Liu L; Chavan R; Feinberg MB
    BMC Immunol; 2008 Apr; 9():15. PubMed ID: 18412969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
    Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
    Front Immunol; 2021; 12():738743. PubMed ID: 34630420
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis.
    Grouard G; Clark EA
    Curr Opin Immunol; 1997 Aug; 9(4):563-7. PubMed ID: 9287189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association of Neisseria gonorrhoeae Opa(CEA) with dendritic cells suppresses their ability to elicit an HIV-1-specific T cell memory response.
    Yu Q; Chow EM; McCaw SE; Hu N; Byrd D; Amet T; Hu S; Ostrowski MA; Gray-Owen SD
    PLoS One; 2013; 8(2):e56705. PubMed ID: 23424672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.